Product Information
ERYTHROMYCIN-BENZOYL GEL is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.0332 per GM under NDC 64980032802. Its NADAC has been published 472 times since Sep 20, 2017.
FDA first approved this application on Sep 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 30 mg/g; mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
64980032802
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA065385FDA Approved
9/18/2015
TE Code
AB
On Market Since
10/18/2016
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN-BENZOYL GEL has been published 472 times since Sep 20, 2017, and over the history we have for it it has declined 74.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0332 per GM |
|---|---|
| All-time high | $4.0979 (Oct 11, 2017) |
| All-time low | $0.7100 (Jul 17, 2024) |
| 52-week high | $1.0520 |
| 52-week low | $0.9067 |
| Median price | $1.1656 |
| Average price | $1.6300 |
| Largest weekly change | +46.4% (Mar 23, 2022) |
| Weeks tracked | 472 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN-BENZOYL GEL?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN-BENZOYL GEL, manufactured by Rising Pharma Holdings Inc., is $1.0332 per GM (NDC 64980032802), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN-BENZOYL GEL changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN-BENZOYL GEL has declined 74.8%. It has been tracked across 472 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN-BENZOYL GEL?
Since Sep 20, 2017, the NADAC for ERYTHROMYCIN-BENZOYL GEL has ranged from a low of $0.7100 (Jul 17, 2024) to a high of $4.0979 (Oct 11, 2017), with a median of $1.1656 per GM.
Are there cheaper alternatives to ERYTHROMYCIN-BENZOYL GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN-BENZOYL GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN-BENZOYL GEL?
ERYTHROMYCIN-BENZOYL GEL (NDC 64980032802) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.